← Back to headlines
Piper Sandler Cuts Amphastar Pharmaceuticals Price Target Amid Uncertainty
Piper Sandler has cut its price target for Amphastar Pharmaceuticals, Inc. to $21, citing pipeline uncertainty, while also raising the price target for Unity Software.
2 Jun, 13:05 — 2 Jun, 13:05
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: seeking-alpha · 2 Jun, 13:05|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
